Literature DB >> 19332526

Identification of children with language impairment: investigating the classification accuracy of the MacArthur-Bates Communicative Development Inventories, Level III.

Elizabeth Skarakis-Doyle1, Wenonah Campbell, Lynn Dempsey.   

Abstract

PURPOSE: This study tested the accuracy with which the MacArthur-Bates Communicative Development Inventories, Level III (CDI-III), a parent report measure of language ability, discriminated children with language impairment from those developing language typically.
METHOD: Parents of 58 children, 49 with typically developing language (age 30 to 42 months) and 9 with language impairment (age 31 to 45 months) completed the CDI-III, a 2-page questionnaire that includes 100 vocabulary items, 12 sentence pairs, and 12 questions regarding linguistic concepts.
RESULTS: A discriminant analysis indicated that the CDI-III total score together with age classified children into language status groups with 96.6% accuracy overall. The corresponding likelihood ratios supported this strong level of accuracy, although precision may not be as high as indicated by broad confidence intervals.
CONCLUSIONS: Results of this study contribute to the accumulating evidence on the types of valid inferences that may be made from the CDI-III, specifically its classification accuracy. Further research should continue to investigate classification accuracy in larger samples with broader maternal education levels and with different types of language impairments. Additional research should also investigate the classification accuracy when the CDI-III is used in combination with other tests.

Entities:  

Mesh:

Year:  2009        PMID: 19332526     DOI: 10.1044/1058-0360(2009/08-0035)

Source DB:  PubMed          Journal:  Am J Speech Lang Pathol        ISSN: 1058-0360            Impact factor:   2.408


  8 in total

1.  Who Receives Speech/Language Services by 5 Years of Age in the United States?

Authors:  Paul L Morgan; Carol Scheffner Hammer; George Farkas; Marianne M Hillemeier; Steve Maczuga; Michael Cook; Stephanie Morano
Journal:  Am J Speech Lang Pathol       Date:  2016-05-01       Impact factor: 2.408

2.  Enalapril in infants with single ventricle: results of a multicenter randomized trial.

Authors:  Daphne T Hsu; Victor Zak; Lynn Mahony; Lynn A Sleeper; Andrew M Atz; Jami C Levine; Piers C Barker; Chitra Ravishankar; Brian W McCrindle; Richard V Williams; Karen Altmann; Nancy S Ghanayem; Renee Margossian; Wendy K Chung; William L Border; Gail D Pearson; Mario P Stylianou; Seema Mital
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

3.  Who Is At Risk for Persistent Mathematics Difficulties in the United States?

Authors:  Paul L Morgan; George Farkas; Marianne M Hillemeier; Steve Maczuga
Journal:  J Learn Disabil       Date:  2014-10-20

4.  Late Talkers: A Population-Based Study of Risk Factors and School Readiness Consequences.

Authors:  Carol Scheffner Hammer; Paul Morgan; George Farkas; Marianne Hillemeier; Dana Bitetti; Steve Maczuga
Journal:  J Speech Lang Hear Res       Date:  2017-03-01       Impact factor: 2.297

5.  24-Month-Old Children With Larger Oral Vocabularies Display Greater Academic and Behavioral Functioning at Kindergarten Entry.

Authors:  Paul L Morgan; George Farkas; Marianne M Hillemeier; Carol Scheffner Hammer; Steve Maczuga
Journal:  Child Dev       Date:  2015-08-18

6.  Psychometric Properties of Child (0-5 Years) Outcome Measures as used in Randomized Controlled Trials of Parent Programs: A Systematic Review.

Authors:  Nicole Gridley; Sarah Blower; Abby Dunn; Tracey Bywater; Maria Bryant
Journal:  Clin Child Fam Psychol Rev       Date:  2019-09

7.  Development and norming of the Hungarian CDI-III: A screening tool for language delay.

Authors:  Bence Kas; Zoltán Jakab; József Lőrik
Journal:  Int J Lang Commun Disord       Date:  2022-01-08       Impact factor: 2.909

8.  The Swedish Communicative Development Inventory III: Parent reports on language in preschool children.

Authors:  Mårten Eriksson
Journal:  Int J Behav Dev       Date:  2016-04-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.